Kyungchul Song, Eunju Lee, Hye Sun Lee, Hana Lee, Hyun Wook Chae, Yu-Jin Kwon
{"title":"Comparison of single-point insulin sensitivity estimator and other markers to predict metabolic syndrome in children and adolescents.","authors":"Kyungchul Song, Eunju Lee, Hye Sun Lee, Hana Lee, Hyun Wook Chae, Yu-Jin Kwon","doi":"10.1016/j.orcp.2025.08.008","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Reliable markers are crucial for the early detection and management of pediatric metabolic syndrome (MS).</p><p><strong>Methods: </strong>1593 children and adolescents were included from Korea National Health and Nutrition Examination Survey 2019-2021. We assessed homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides-glucose index (TyG), triglycerides/high-density lipoprotein cholesterol (TG/HDL), the Metabolic Score for IR (METS-IR), and single-point insulin sensitivity estimator (SPISE) as predictors of MS. Logistic regression analysis was employed for MS according to the parameters. Receiver operating characteristic (ROC) curves were plotted, and the area under the curve (AUC) was calculated to compare the markers to predict MS.</p><p><strong>Results: </strong>In logistic regression analyses, HOMA-IR, METS-IR, TyG, TG/HDL, and SPISE scores were significantly associated with the prevalence of MS after adjusting for age, sex and body mass index standard deviation score. In ROC curve, AUCs (95 % confidence intervals) for IDF-defined MS according to HOMA-IR, METS-IR, TyG, TG/HDL, and SPISE were 0.884 (0.848-0.920), 0.959 (0.945 -0.972), 0.922 (0.889-0.954), 0.941 (0.913-0.969), and 0.961 (0.947-0.975), respectively, and those for NCEP-ATP Ⅲ-defined MS were 0.886 (0.828-0.900), 0.959 (0.946 -0.972), 0.915 (0.891-0.938), 0.942 (0.925-0.959), and 0.965 (0.954-0.977), respectively. SPISE was superior to all other markers for prediction of NCEP ATP Ⅲ-defined MS. For predicting IDF-defined MS, AUCs of METS-IR, TG/HDL, and SPISE were higher than those of HOMA-IR and TyG.</p><p><strong>Conclusion: </strong>These findings highlight the potential of SPISE and METS-IR for early identification and intervention of MS in children and adolescents.</p>","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity research & clinical practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.orcp.2025.08.008","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Reliable markers are crucial for the early detection and management of pediatric metabolic syndrome (MS).
Methods: 1593 children and adolescents were included from Korea National Health and Nutrition Examination Survey 2019-2021. We assessed homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides-glucose index (TyG), triglycerides/high-density lipoprotein cholesterol (TG/HDL), the Metabolic Score for IR (METS-IR), and single-point insulin sensitivity estimator (SPISE) as predictors of MS. Logistic regression analysis was employed for MS according to the parameters. Receiver operating characteristic (ROC) curves were plotted, and the area under the curve (AUC) was calculated to compare the markers to predict MS.
Results: In logistic regression analyses, HOMA-IR, METS-IR, TyG, TG/HDL, and SPISE scores were significantly associated with the prevalence of MS after adjusting for age, sex and body mass index standard deviation score. In ROC curve, AUCs (95 % confidence intervals) for IDF-defined MS according to HOMA-IR, METS-IR, TyG, TG/HDL, and SPISE were 0.884 (0.848-0.920), 0.959 (0.945 -0.972), 0.922 (0.889-0.954), 0.941 (0.913-0.969), and 0.961 (0.947-0.975), respectively, and those for NCEP-ATP Ⅲ-defined MS were 0.886 (0.828-0.900), 0.959 (0.946 -0.972), 0.915 (0.891-0.938), 0.942 (0.925-0.959), and 0.965 (0.954-0.977), respectively. SPISE was superior to all other markers for prediction of NCEP ATP Ⅲ-defined MS. For predicting IDF-defined MS, AUCs of METS-IR, TG/HDL, and SPISE were higher than those of HOMA-IR and TyG.
Conclusion: These findings highlight the potential of SPISE and METS-IR for early identification and intervention of MS in children and adolescents.
期刊介绍:
The aim of Obesity Research & Clinical Practice (ORCP) is to publish high quality clinical and basic research relating to the epidemiology, mechanism, complications and treatment of obesity and the complication of obesity. Studies relating to the Asia Oceania region are particularly welcome, given the increasing burden of obesity in Asia Pacific, compounded by specific regional population-based and genetic issues, and the devastating personal and economic consequences. The journal aims to expose health care practitioners, clinical researchers, basic scientists, epidemiologists, and public health officials in the region to all areas of obesity research and practice. In addition to original research the ORCP publishes reviews, patient reports, short communications, and letters to the editor (including comments on published papers). The proceedings and abstracts of the Annual Meeting of the Asia Oceania Association for the Study of Obesity is published as a supplement each year.